Clinical Trial Update: Protocol for Primary Fractionated Stereotactic Body Radiation Therapy for Stage T1 - T3N0 Non Small Cell Lung Carcinoma. [Phase 2]

View source ↗

Summary

Protocol for a Phase 2 study evaluating primary fractionated stereotactic body radiation therapy for early-stage (T1-T3N0) non-small cell lung cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-small Cell Lung Cancer

Snippet

Sponsor: Universitair Ziekenhuis Brussel | Conditions: Non Small Cell Lung Carcinoma | Phase 2 | Status: UNKNOWN